CFAR-NIDA Training Grant

Brown University
Timothy Flanigan, M.D., Principal Investigator

Timothy Flanigan, MD, Chief of Infectious Diseases at Brown is the Principal Investigator of the NIH NIDA-CFAR fellowship program. He has extensive experience mentoring junior faculty members in the early diagnosis of disease, HIV prevention, and adherence interventions among substance abusers.

The NIH/NIDA funded T32 (DA-13911) entitled Prevention, Diagnosis, and Treatment of HIV and Other Infectious Diseases Among Substance Abusers provides additional opportunities for Infectious Disease Fellows to pursue two years of clinical research training in a subject related to diagnosis, prevention, or treatment of HIV, Hepatitis B and C, STDs, tuberculosis, or bacterial infections related to substance abuse. In addition, fellows have the opportunity to obtain an MPH or other advanced coursework as appropriate through the T32. The grant uses a multidisciplinary approach toward the understanding, prevention, and treatment on the infectious complications of drug abuse. The grant strengthens the unique CFAR research focus on HIV and its connection with substance abuse.

Under the grant, physicians, postdoctoral and predoctoral fellows with backgrounds in internal medicine, infectious diseases, pediatrics, OB/GYN, psychiatry and behavioral medicine are encouraged to receive advanced training in the areas of HIV, STDs, TB, hepatitis, and other diseases that occur frequently among substance abusing populations.

The training takes advantage of the combined resources of The Miriam Hospital's Immunology Center, Brown Medical School and affiliated hospitals, Tufts University affiliates, specialized centers and clinics, such as the Rhode Island Adult Correctional Institute (ACI), and community drug treatment centers and offers a rich, hands on environment for each Fellow.